Wize Pharma Receives Bonus BioGroup Shares from Escrow and Additional Bonus
04 Jan 2021 //
PRNEWSWIRE
Wize Pharma Receives Bonus BioGroup Shares from Escrow and Additional Bonus
04 Jan 2021 //
BIOSPACE
Wize Pharma and Cosmos Capital enter into Bid Implementation Agreement
30 Dec 2020 //
PRNEWSWIRE
Wize Pharma Announces Positive Topline Results in Phase IV Study of LO2A
11 Nov 2020 //
PRNEWSWIRE
Wize Pharma`s Strategic Transaction Partner Bonus BioGroup MesenCure Data
27 May 2020 //
PRNEWSWIRE
Wize Pharma`s Strategic Transaction Partner Bonus BioGroup Reports
18 May 2020 //
PRNEWSWIRE
Wize Pharma Completes PhIV Study of LO2A for the Treatment of Dry Eye Syndrome
07 May 2020 //
PRNEWSWIRE
Wize Pharma`s Strategic Transaction Partner Bonus Initiates Preclinical Study
21 Apr 2020 //
PR NEWSWIRE
Wize Pharma completes patient enrollment in phase IV study of LO2A
24 Feb 2020 //
PHARMABIZ
Wize Pharma Completes Patient Enrollment In Phase IV Study Of LO2A •
21 Jan 2020 //
PR NEWSWIRE
Wize Pharma Executes Agreements for Strategic Transaction With Bonus BioGroup
16 Jan 2020 //
PR NEWSWIRE
Cannabics Pharmaceuticals Closes Agreement With Wize Pharma
06 Mar 2019 //
PR NEWSWIRE
Cannabics Pharms, Wize Pharma Joint Venture to Develop Ophthalmic Therapeutics
07 Feb 2019 //
PR NEWSWIRE
Wize Pharma, Inc. Announces Closing of $4.45 Million Private Placement
26 Oct 2018 //
PR NEWSWIRE